Why Mylan (MYL) Hit an All-Time High Today

NEW YORK (TheStreet) -- Mylan  (MYL) soared to an all-time high of $57.06 as of 2:57 p.m. EST on Thursday after the pharmaceutical company reported fourth-quarter earnings that surpassed analysts' expectations.

The company noted earnings of 78 cents a share, excluding items, which surpassed the Capital IQ consensus estimate of 75 cents a share. Revenue rose 5.9% year over year to $1.81 billion, which equaled the consensus estimate.

Mylan also issued guidance for the fiscal year 2014 and expects earnings per share of $3.25 to $3.60 and revenue of $7.8 billion to $8.2 billion. The Capital IQ consensus estimate calls for $3.43 a share on revenue of $7.73 billion.

Must Read: An Intraday Snapshot

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

MYL Chart

MYL data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%